Clinical Trials · NCT04839237
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Xiangya Hospital of Central South University
- Enrollment
- 0
- Start date
- Dec 2017
- Locations
- 1 site, China
- Primary endpoint
- Weight Change at 3 months